Background: To secure the gains of lymphatic filariasis (LF) elimination programs, attention is needed to the 'residual microfilaremia phase', in which high-risk populations may be crucial. The present study documents the impact of mass drug administration (MDA) in the urban Indian setting of Surat City, with high rates of in-migration.

Methods: Epidemiological assessment included National Filaria Control Program (NFCP) and World Health Organization recommended routine and pre-MDA microfilaremia surveys respectively. Routine filaria surveys were conducted around the year in approximately 2000-4000 people per month, while pre-MDA surveys were carried out annually among approximately 4000 people from four fixed and four random sites. In 2016, Transmission Assessment Survey (TAS) was done in primary school children. The outcomes were microfilaremia (Mf) and antigen prevalence; more specifically, microfilaremia according to place of birth, in pre-MDA and routine night blood smears (NBS) collected from 2008 to 2015. Prevalence ratios and confidence intervals were calculated.

Results: A total of 25 480 pre-MDA and 306 198 routine NBS were examined during the study. In 2008, the Mf prevalence in the routine survey was 63/18 814 (0.33%), declining to 23/39 717 (0.06%) in 2016. Pre-MDA surveys showed a similar decrease from 47/4184 (1.1%) in 2008 to 12/4042 (0.3%) in 2015. In those born outside Surat, microfilaremia decreased below transmission thresholds, but remained more than treble that of the remainder of the population, in both the pre-MDA surveys [prevalence ratio: 3.17, 95% confidence interval (CI): 1.15-8.72], and the routine surveys (3.31, 95% CI: 1.47-7.48). Though the TAS results indicated that MDA endpoints had been reached, sub-group analysis identified that 90% of antigenemic children were from families of high-risk groups.

Conclusions: Extensive long-term epidemiological monitoring suggests that all the urban population, including high-risk groups, have benefitted from the ELF program. To prevent re-establishment of infection in large urban areas with unsanitary conditions conducive to filarial vector breeding, there is need to identify residual microfilaremia by customized surveys in addition to pre-MDA monitoring and TAS. The present findings can be used to develop strategies to prioritize screening, surveillance and plan treatment of high-risk groups after achieving MDA endpoints.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130313PMC
http://dx.doi.org/10.1186/s40249-021-00856-xDOI Listing

Publication Analysis

Top Keywords

pre-mda surveys
12
lymphatic filariasis
8
filariasis elimination
8
urban indian
8
indian setting
8
residual microfilaremia
8
mass drug
8
drug administration
8
mda endpoints
8
high-risk groups
8

Similar Publications

Article Synopsis
  • The study investigates the coverage and effectiveness of Mass Drug Administration (MDA) for addressing high microfilaria rates in several districts of Uttar Pradesh, India, aiming to identify factors that influence effective coverage.
  • Conducted through a community-based cross-sectional approach, the study sampled 4,151 participants and found coverage rates between 49.8% and 87.9%, with effective coverage ranging from 51.8% to 73.2%, but the lowest compliance was noted in Sultanpur at 70.7%.
  • The research concludes that while drug compliance is generally good, effective coverage is lacking, highlighting the need for targeted informational campaigns before MDA to alleviate fears about potential side effects and to encourage community involvement
View Article and Find Full Text PDF

Background: Mass drug administration (MDA) is a powerful tool for malaria control, but the medicines to use, dosing, number of rounds, and potential selection of drug resistance remain open questions.

Methods: Two monthly rounds of artemisinin-piperaquine (AP), each comprising 2 daily doses, were administered across the 7 districts of Grande Comore Island. In 3 districts, low-dose primaquine (PMQ) was also given on the first day of each monthly round.

View Article and Find Full Text PDF

Background: To secure the gains of lymphatic filariasis (LF) elimination programs, attention is needed to the 'residual microfilaremia phase', in which high-risk populations may be crucial. The present study documents the impact of mass drug administration (MDA) in the urban Indian setting of Surat City, with high rates of in-migration.

Methods: Epidemiological assessment included National Filaria Control Program (NFCP) and World Health Organization recommended routine and pre-MDA microfilaremia surveys respectively.

View Article and Find Full Text PDF

Lymphatic filariasis in Fiji: progress towards elimination, 1997-2007.

Trop Med Health

October 2020

College of Public Health, Medical and Veterinary Sciences and JCU WHO Collaborating Centre for Vector-Borne and Neglected Tropical Diseases, College of Public Health, James Cook University, Cairns and Townsville, Queensland Australia.

Background: Lymphatic filariasis (LF) is a major public health problem in the Pacific Region, including in Fiji. Through transmission by the mosquito vector , Fiji has suffered the burden of remaining endemic with LF despite efforts at elimination prior to 1999. In the year 1999, Fiji agreed to take part in the Pacific Programme for Elimination of LF (PacELF) and the Global Programme to Eliminate LF.

View Article and Find Full Text PDF

Background: Lymphatic filariasis (LF) is widely endemic in Côte d'Ivoire, and elimination as public health problem (EPHP) is based on annual mass drug administration (MDA) using ivermectin and albendazole. To guide EPHP efforts, we evaluated Wuchereria bancrofti infection indices among humans, and mosquito vectors after four rounds of MDA in four cross-border health districts of Côte d'Ivoire.

Methodology: We monitored people and mosquitoes for W.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!